Is Antibe Therapeutics Inc. (ATBPF) a Buy, Sell, or Hold?
OTC : ATBPF
Antibe Therapeutics Inc. — Competitors
$0.2156 USD
$0.0 (-0.19%)
- Volume
- 17.94K
- Average Volume
- 9.5K
- Market Capitalization
- $11.43M
- P/E Ratio
- -0.80
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.22
- Year Low
- $0.19
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $15.03
ATBPF vs. The Competition
| Properties | ATBPF | CDXFF | CNPOF | EIGRQ |
|---|---|---|---|---|
| Market Cap | $11.43M | $9.75M | $10.96M | $12.59M |
| Shares Outstanding | $53.01M | $103.16M | $136.97M | $1.48M |
| P/E Ratio | -0.8 | -1.14 | -0.15 | -0.17 |
| EPS | -0.37 | -0.11 | -0.63 | -50.78 |
| Day Low | 0.1889 | 0.0945 | 0.07 | 8 |
| Day High | 0.2156 | 0.0945 | 0.08 | 8.5 |
| Year Low | 0.1889 | 0.084 | 0.0621 | 1.1 |
| Year High | 0.216 | 0.0945 | 0.169 | 16 |
| Average Price 50 | 0.216 | 0.084 | 0.1073014 | 11.27 |
| Average Price 200 | 0.216 | 0.084 | 0.10469725 | 6.94462 |
| Volume | 17935 | 12000 | 10100 | 725 |
| Average Volume | - | - | - | - |